ARX · ASX

Aroa Biosurgery Ltd (ASX:ARX)

AU$0.61

 -0.03 (-4.688%)
ASX:Live
26/08/2025 04:10:22 PM
Near Resistance HALO Price Momentum HALO Ords HALO Momentum HALO Growth +5
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

ARX Overview

ARX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Strong

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Weak

About ARX

Website

Aroa Biosurgery Ltd

Telephone

64.9.869.3035

Address

64 Richard Pearse Drive Mangere, Auckland 2022

Description

Aroa Biosurgery Ltd. engages in the development, manufacturing, and marketing of soft tissue repair products. It focuses on healing for complex wounds, and soft tissue reconstruction procedures including abdominal wall reconstruction, breast reconstruction, and reconstructive surgery for trauma, limb salvage, and tumor resections. The company was founded by Brian Roderick Ward in 2008 and is headquartered in Mangere, New Zealand.

ARX Price Chart

Key Stats

Market Cap

AU$220.82M

PE

743.10

EV/EBITDA

57.8

Dividends Overview

DIV Yield

.0%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.35 - 0.81

Trade Value (12mth)

US$29,193.00

1 week

0.79%

1 month

12.28%

YTD

-14.09%

1 year

33.33%

All time high

1.75

Key Fundamentals

EPS 3 yr Growth

-54.70%

EBITDA Margin

1.10%

Operating Cashflow

-$3m

Free Cash Flow Return

-2.60%

ROIC

-3.80%

Interest Coverage

2.00

Quick Ratio

5.80

Other Data

Shares on Issue (Fully Dilluted)

345m

HALO Sector

Healthcare

Next Company Report Date

28-May-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

NZD

Short Sell (% of issue)

0.00

ARX Announcements

Latest Announcements

Date Announcements

20 August 25

Chairman's Address - AGM

×

Chairman's Address - AGM

20 August 25

CEO Presentation - AGM

×

CEO Presentation - AGM

20 August 25

Results of Annual General Meeting

×

Results of Annual General Meeting

06 August 25

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

29 July 25

June 2025 Quarterly Report and Appendix 4C

×

June 2025 Quarterly Report and Appendix 4C

29 July 25

Investor Presentation

×

Investor Presentation

25 July 25

Notification of cessation of securities - ARX

×

Notification of cessation of securities - ARX

25 July 25

Change of Director's Interest Notice - BW

×

Change of Director's Interest Notice - BW

25 July 25

Change of Director's Interest Notice - JM

×

Change of Director's Interest Notice - JM

25 July 25

Change of Director's Interest Notice - JP

×

Change of Director's Interest Notice - JP

25 July 25

Change of Director's Interest Notice - PM

×

Change of Director's Interest Notice - PM

22 July 25

Notification of Quarterly Results Webinar

×

Notification of Quarterly Results Webinar

11 July 25

Notification of Cessation of Securities - Correction

×

Notification of Cessation of Securities - Correction

11 July 25

Notification of cessation of securities - ARX

×

Notification of cessation of securities - ARX

27 June 25

Annual Report to Shareholders

×

Annual Report to Shareholders

27 June 25

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

25 June 25

Notice of AGM Date and Director Nomination Closing Date

×

Notice of AGM Date and Director Nomination Closing Date

19 June 25

Application for quotation of securities - ARX

×

Application for quotation of securities - ARX

17 June 25

Notification of cessation of securities - ARX

×

Notification of cessation of securities - ARX

17 June 25

Change of Director's Interest Notice - BW

×

Change of Director's Interest Notice - BW

11 June 25

Change of Director's Interest Notice - JD

×

Change of Director's Interest Notice - JD

30 May 25

Change of Share Registry Details

×

Change of Share Registry Details

29 May 25

FY25 Appendix 4E and Full Year Results

×

FY25 Appendix 4E and Full Year Results

29 May 25

FY25 Full Year Results Presentation

×

FY25 Full Year Results Presentation

13 May 25

Notification of Full Year Results Webinar - New Date

×

Notification of Full Year Results Webinar - New Date

ARX Fundamentals

Per Share Records

Historical data

Forecast data

NZD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.00 -0.03 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.00 -0.03 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 95.5 -2,721.0 64.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A 673.0 743.1 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A 71.8 57.8 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.02 -0.00 0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.03 -0.03 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 793.4 -110.8 857.7 Lock Lock Lock
     Yield % Lock Lock Lock Lock -2.5 -5.3 -3.0 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A 0.0 0.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.30 0.28 0.27 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.25 0.22 0.21 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.1 -11.0 -1.9 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 343 344 345 Lock Lock Lock
Basic m Lock Lock Lock Lock 343 344 345 Lock Lock Lock

Financial Records

Historical data

Forecast data

NZD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Income Statement
Sales $m Lock Lock Lock Lock 63 69 85 Lock Lock Lock
     Growth % Lock Lock Lock Lock 59.7 9.0 22.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 58 71 77 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 53 59 73 Lock Lock Lock
     Growth % Lock Lock Lock Lock 75.3 11.4 23.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 83.5 85.4 85.7 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 16 15 14 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -1 -8 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 82.0 -690.0 111.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.6 -11.5 1.1 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 4 4 5 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -5 -12 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 44.3 -154.6 67.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -7.7 -17.9 -4.7 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 0 -12 -4 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 -1 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 0 -11 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 95.3 -2,583.8 64.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.6 -15.4 -4.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -4 -7 -3 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 8 7 4 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 7 10 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -10 -11 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 38.7 -11.2 55.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.2 -0.2 -0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 46 30 22 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 117 111 109 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 7 6 5 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -39 -23 -16 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 15 16 16 Lock Lock Lock
Equity $m Lock Lock Lock Lock 104 94 93 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 108 101 98 Lock Lock Lock
     Growth % Lock Lock Lock Lock 2.5 -6.5 -2.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -0.3 -9.6 -3.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -0.4 -11.3 -4.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -4.4 -11.7 -4.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -0.4 -10.1 -3.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -3.4 -7.0 -2.6 Lock Lock Lock

Ratios Records

Historical data

Forecast data

NZD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Leverage
Interest Cover X Lock Lock Lock Lock -2.7 -16.2 2.0 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 38.8 2.9 -16.7 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -37.4 -24.3 -16.9 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 9.9 7.3 6.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 9.3 6.4 5.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 59.0 43.8 32.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -47.7 -77.5 -24.9 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 2.9 2.5 2.6 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 2.3 1.6 1.5 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.9 1.2 1.5 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 3.1 2.4 2.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 0.6 0.8 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 0.6 0.8 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -0.6 -17.5 -4.9 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -0.3 -10.9 -3.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -0.3 -9.6 -3.5 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.2 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -0.4 -11.3 -4.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -0.4 -11.3 -4.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 157.1 232.6 247.9 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 126.3 144.0 138.8 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 283.4 376.7 386.6 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 53.2 49.8 50.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 230.2 326.9 335.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.0%

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.10%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ARX Shortsell

Frequently Asked Questions

The current share price of Aroa Biosurgery Ltd (ARX:ASX) is AU$0.61.
The 52-week high share price for Aroa Biosurgery Ltd (ARX:ASX) is AU$0.81.
The 52-week low share price for Aroa Biosurgery Ltd (ARX:ASX)? is AU$0.35.
The current TTM dividend payout for Aroa Biosurgery Ltd (ARX:ASX) is 0.00.
Aroa Biosurgery Ltd (ARX:ASX) does not pay a dividend.
Aroa Biosurgery Ltd (ARX:ASX) has a franking level of 0.0%.
Aroa Biosurgery Ltd (ARX:ASX) is classified in the Healthcare.
The current P/E ratio for Aroa Biosurgery Ltd (ARX:ASX) is 743.10.
The current share price of Aroa Biosurgery Ltd (ARX:ASX) is AU$0.61.
The 52-week high share price for Aroa Biosurgery Ltd (ARX:ASX) is AU$0.81.
The 52-week low share price for Aroa Biosurgery Ltd (ARX:ASX)? is AU$0.35.
The current TTM dividend payout for Aroa Biosurgery Ltd (ARX:ASX) is 0.00.
Aroa Biosurgery Ltd (ARX:ASX) does not pay a dividend.
Aroa Biosurgery Ltd (ARX:ASX) has a franking level of 0.0%.
Aroa Biosurgery Ltd (ARX:ASX) is classified in the Healthcare.
The current P/E ratio for Aroa Biosurgery Ltd (ARX:ASX) is 743.10.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.